Adagio Medical Holdings Inc ADGM
π Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2021-02-26 |
| Shares Out. | 22,210,000 |
| Website | perceptivelife.com/arya4/ β |
| Phone | 19493481188 |
| Employees | 41 |
About Adagio Medical Holdings Inc
Adagio Medical Holdings Inc is a medical device company focused on developing and commercializing products for the treatment of cardiac arrhythmias with its proprietary, catheter-based Ultra-Low Temperature Ablation (ULTA) technology. UTLA is designed to create large, durable lesions extending through the depth of both diseased and healthy cardiac tissue. The company is currently focused on the treatment of ventricular tachycardia (VT), a rapid, abnormal heart rhythm, or arrhythmia, that originates in the heart's lower chambers, or ventricles. The company has one reportable segment.
Adagio Medical Holdings Inc is a publicly traded company under the ticker symbol ADGM on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
π Analyst Ratings
9 analysts (2026-07-01)

